NewKerala.com

Key Points

A groundbreaking study from Tianjin Medical University has uncovered a remarkable potential for statins in treating sepsis patients. Researchers found that statin treatment could reduce death rates by an impressive 39% in critically ill patients over 28 days. The study analyzed 12,140 patients, revealing significant implications for managing this life-threatening condition. While some additional medical interventions might be slightly prolonged, the overall survival benefits represent a major breakthrough in sepsis treatment.

Key Points: Statins Cut Sepsis Death Risk by 39% in Breakthrough Study

  • Statins show significant potential in reducing sepsis-related mortality
  • Large cohort study reveals 39% lower death rate
  • Anti-inflammatory properties may help combat severe infection complications
  • Promising new approach to treating critical patient care
2 min read

Statins may reduce death risk in sepsis patients: Study

Groundbreaking research reveals statins' potential to dramatically reduce mortality rates in critically ill sepsis patients, offering new hope for treatment.

"Statins may provide a protective effect and improve clinical outcomes for patients with sepsis - Dr. Caifeng Li"

New Delhi, June 6

Statins, typically used to lower blood pressure may also help lower the risk of death among patients suffering from deadly sepsis by 39 per cent, according to a study on Friday.

Sepsis occurs when the immune system overreacts to an infection, causing such a strong inflammatory response that vital organs begin to shut down. It is life-threatening, as in about 15 per cent of cases, sepsis worsens into septic shock, characterised by dangerously low blood pressure and reduced blood flow to tissues.

The risk of death from septic shock is even higher, between 30 per cent and 40 per cent.

The earlier patients with sepsis are treated, the better their prospects. Typically, they receive antibiotics, intravenous fluids, and vasopressors to raise blood pressure.

However, the large cohort study published in the journal Frontiers in Immunology has shown for the first time that supplementary treatment with statins could boost their chances of survival.

“Our large, matched cohort study found that treatment with statins was associated with a 39 per cent lower death rate for critically ill patients with sepsis when measured over 28 days after hospital admission,” said Dr Caifeng Li, Associate Professor at Tianjin Medical University General Hospital in China.

Statins are best known for their protective effect against cardiovascular disease, which functions by lowering ‘bad’ LDL cholesterol and triglycerides, and raising ‘good’ HDL cholesterol.

“Statins have anti-inflammatory, immunomodulatory, antioxidative, and antithrombotic properties. They may help mitigate excessive inflammatory response, restore endothelial function, and show potential antimicrobial activities,” said Li.

The researchers built a statistical model for the study and analysed 6,070 critical patients who received statins and another 6,070 who did not.

The results showed that the 28-day all-cause mortality rate was 14.3 per cent in the statin group and 23.4 per cent in the no-statin group, indicating a relative reduction of 39 per cent.

However, the duration of mechanical ventilation (MV) or continuous renal replacement therapy (CRRT) increased by an average of 3 hours and 26 hours, respectively, in the group receiving statins. This prolonged duration of MV and CRRT in the statin group may be attributed to a trade-off between 28-day all-cause mortality and the duration of MV or CRRT.

“These results strongly suggest that statins may provide a protective effect and improve clinical outcomes for patients with sepsis,” Li said.

- IANS

Share this article:

Reader Comments

R
Rajesh K.
This is promising research! My uncle suffered from sepsis last year and it was a traumatic experience for our family. If statins can help reduce mortality by 39%, it could save so many lives. Hope Indian hospitals adopt this soon. 🙏
P
Priya M.
Interesting study but I wonder about the side effects. Statins are already controversial for long-term use. The increased duration of mechanical ventilation is concerning. More research needed before this becomes standard treatment protocol.
A
Amit S.
As someone working in healthcare, I appreciate studies like these. Sepsis is a silent killer in India too. The anti-inflammatory properties of statins make sense theoretically. But implementation will be challenging in government hospitals with limited resources.
S
Sunita P.
Good to see medical research progressing! But will this be affordable for common people? Statins aren't cheap and many Indians can't afford advanced treatments. Government should consider subsidizing if this proves effective.
V
Vikram J.
The study is from China - we need similar research in Indian population. Our genetic makeup and health conditions are different. AIIMS or other premier institutes should conduct trials here before we jump to conclusions.
N
Neha R.
My mother takes statins for cholesterol. If the same medicine can help in sepsis cases, that's amazing! But doctors should be careful about dosage - too much of anything can be harmful. #HealthAwareness

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50